The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Inhibition of JAK1, 2/STAT3 Signaling Induces Apoptosis, Cell Cycle Arrest, and Reduces Tumor Cell Invasion in Colorectal Cancer Cells
Open accessAbstract
Abnormalities in the STAT3 pathway are involved in the oncogenesis of several cancers. However, the mechanism by which dysregulated STAT3 signaling contributes to the progression of human colorectal cancer (CRC) has not been elucidated, nor has the role of JAK, the physiological activator of STAT3, been evaluated. To investigate the role of both JAK and STAT3 in CRC progression, we inhibited JAK with AG490 and depleted STAT3 with a SiRNA. Our results demonstrate that STAT3 and both JAK1 and 2 are involved in CRC cell growth, survival, invasion, and migration through regulation of gene expression, such as Bcl-2, p1(6ink4a), p21(waf1/cip1), p27(kip1), E-cadherin, VEGF, and MMPs. Importantly, the FAK is not required for STAT3-mediated regulation, but does function downstream of JAK. In addition, our data show that proteasome-mediated proteolysis promotes dephosphorylation of the JAK2, and consequently, negatively regulates STAT3 signaling in CRC. Moreover, immunohistochemical staining reveals that nuclear staining of phospho-STAT3 mostly presents in adenomas and adenocarcinomas, and a positive correlation is found between phospho-JAK2 immunoreactivity and the differentiation of colorectal adenocarcinomas. Therefore, our findings illustrate the biologic significance of JAK1, 2/STAT3 signaling in CRC progression and provide novel evidence that the JAK/STAT3 pathway may be a new potential target for therapy of CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Buettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,040
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Tung-Ping Poon, R., Fan, S.-T., & Wong, J. (2000) · Annals of Surgery · doi:10.1097/00000658-200007000-00003 · Cited by 811
A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791
Grandis, J. R., Drenning, S. D., Zeng, Q., Watkins, S. C., Melhem, M. F., Endo, S., Johnson, D. E., Huang, L., He, Y., & Kim, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4227 · Cited by 588
Blaskovich, M. A., Sun, J., Cantor, A. B., Turkson, J., Jove, R., & Sebti, S. M. (2003) · PubMed · Cited by 561
Mora, L. B., Buettner, R., Seigne, J. D., Diaz, J. I., Ahmad, N., Garcia, R., Bowman, T. L., Falcone, R., Fairclough, R., Cantor, A. B., et al. (2002) · PubMed · Cited by 533
Saxena, N. K., Sharma, D., Ding, X., Lin, S., Marra, F., Merlin, D., & Anania, F. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3075 · Cited by 469
Aoki, Y., Feldman, G. M., & Tosato, G. (2003) · Blood · doi:10.1182/blood-2002-07-2130 · Cited by 438
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
Zamo, A., Chiarle, R., Piva, R., Howes, J., Fan, Y., Chilosi, M., Levy, D. E., & Inghirami, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205152 · Cited by 399
Niwa, Y., Kanda, H., Shikauchi, Y., Saiura, A., Matsubara, K., Kitagawa, T., Yamamoto, J., Kubo, T., & Yoshikawa, H. (2005) · Oncogene · doi:10.1038/sj.onc.1208788 · Cited by 339
Wang, Y.-Y., Zhou, G.-B., Yin, T., Chen, B., Shi, J.-Y., Liang, W.-X., Jin, X.-L., You, J.-H., Yang, G., Shen, Z.-X., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408831102 · Cited by 276
Shen, Y., Devgan, G., Darnell, J. E., & Bromberg, J. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1543 · Cited by 249
Alvarez, J. V., Greulich, H., Sellers, W. R., Meyerson, M., & Frank, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3757 · Cited by 240
Activation of STAT3 is a marker of poor prognosis in human colorectal cancer
Kusaba, T., Nakayama, T., Yamazumi, K., Yakata, Y., Yoshizaki, A., Inoue, K., Nagayasu, T., & Sekine, I. (2006) · Oncology Reports · doi:10.3892/or.15.6.1445 · Cited by 238
Dikkopf-1 as a Novel Serologic and Prognostic Biomarker for Lung and Esophageal Carcinomas
Yamabuki, T., Takano, A., Hayama, S., Ishikawa, N., Kato, T., Miyamoto, M., Ito, T., Ito, H., Miyagi, Y., Nakayama, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3369 · Cited by 213
Morita, Y., Naka, T., Kawazoe, Y., Fujimoto, M., Narazaki, M., Nakagawa, R., Fukuyama, H., Nagata, S., & Kishimoto, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090084797 · Cited by 185
Kusaba, T., Nakayama, T., Yamazumi, K., Yakata, Y., Yoshizaki, A., Nagayasu, T., & Sekine, I. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.023416 · Cited by 173
Galizia, G., Lieto, E., De Vita, F., Orditura, M., Castellano, P., Troiani, T., Imperatore, V, & Ciardiello, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210381 · Cited by 161
Fornaro, M., Plescia, J., Chheang, S., Tallini, G., Zhu, Y.-M., King, M., Altieri, D. C., & Languino, L. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307627200 · Cited by 155
Molecular causes of colon cancer
Oving, I. M., & Clevers, H. C. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01004.x · Cited by 149
Mottok, A., Renné, C., Willenbrock, K., Hansmann, M., & Bräuninger, A. (2007) · Blood · doi:10.1182/blood-2007-03-082511 · Cited by 142
Amin, H. M., Medeiros, L. J., Ma, Y., Feretzaki, M., Das, P., Leventaki, V., Rassidakis, G. Z., O’Connor, S. L., McDonnell, T. J., & Lai, R. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206849 · Cited by 137
STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas
Walker, S. R., Nelson, E. A., & Frank, D. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209775 · Cited by 136
Kaspar, M., Trachsel, E., & Neri, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0283 · Cited by 131
Zhang, F., Li, C., Halfter, H., & Liu, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206158 · Cited by 125
Profiling markers of prognosis in colorectal cancer.
Lyall, M. S., Dundas, S. R., Curran, S., & Murray, G. I. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1864 · Cited by 122
Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma
Ma, X.-T., Wang, S., Ye, Y.-J., Du, R.-Y., Cui, Z.-R., & Somsouk, M. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i11.1569 · Cited by 119
Mahboubi, K., Li, F., Plescia, J., Kirkiles-Smith, N. C., Mesri, M., Du, Y., Carroll, J. M., Elias, J. A., Altieri, D. C., & Pober, J. S. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780241 · Cited by 114
Laßmann, S., Schuster, I., Walch, A. K., Göbel, H., Jütting, U., Makowiec, F., Hopt, U. T., & Werner, M. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.035113 · Cited by 114
Stat3-Mediated Transformation of NIH-3T3 Cells by the Constitutively Active Q205L Gα o Protein
Ram, P. T., Horvath, C. M., & Iyengar, R. (2000) · Science · doi:10.1126/science.287.5450.142 · Cited by 109
Dambacher, J., Beigel, F., Seiderer, J., Haller, D., Göke, B., Auernhammer, C. J., & Brand, S. (2007) · Gut · doi:10.1136/gut.2006.118679 · Cited by 106
Lu, R., Wang, X., Chen, Z.-F., Sun, D.-F., Tian, X.-Q., & Fang, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608525200 · Cited by 105
Self-citationAutocrine-mediated Activation of STAT3 Correlates with Cell Proliferation in Breast Carcinoma Lines
Li, L., & Shaw, P. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109962200 · Cited by 102
Kunnumakkara, A. B., Nair, S. A., Ahn, K. S., Pandey, M. K., Yi, Z., Liu, M., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2007-01-067256 · Cited by 91
Kanai, M., Konda, Y., Nakajima, T., Izumi, Y., Kanda, N., Nanakin, A., Kubohara, Y., & Chiba, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206109 · Cited by 88
Carón, R. W., Yacoub, A., Li, M., Zhu, X., Mitchell, C., Hong, Y. K., Hawkins, W., Sasazuki, T., Shirasawa, S., Kozikowski, A. P., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.257.4.2 · Cited by 85
Yamashita, H., Iwase, H., Toyama, T., & Fujii, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206277 · Cited by 84
Hecht, M., Papoutsi, M., Tran, H., Wilting, J., & Schweigerer, L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1014 · Cited by 83
Spano, J., Milano, G. A., Rixe, C., & Fagard, R. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.07.006 · Cited by 77
Maurer, G. D., Leupold, J. H., Schewe, D. M., Biller, T., Kates, R. E., Hornung, H.-M., Lau‐Werner, U., Post, S., & Allgayer, H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1668 · Cited by 49
Pecquet, C., Nyga, R., Penard‐Lacronique, V., Smithgall, T. E., Murakami, H., Régnier, A., Lassoued, K., & Gouilleux, F. (2006) · Oncogene · doi:10.1038/sj.onc.1209949 · Cited by 35
Cited by
Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Gupta, S. R., Tharakan, S. T., Koca, C., Dey, S., & Sung, B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04911.x · Cited by 649
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 634
ROCK and JAK1 Signaling Cooperate to Control Actomyosin Contractility in Tumor Cells and Stroma
Sanz-Moreno, V., Gaggioli, C., Yeo, M., Albrengues, J., Wallberg, F., Viros, A., Hooper, S., Mitter, R., Féral, C. C., Cook, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.018 · Cited by 409
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes
Kim, T.-M., Laird, P. W., & Park, P. J. (2013) · Cell · doi:10.1016/j.cell.2013.10.015 · Cited by 380
The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer
WANG, S.-W., & SUN, Y.-M. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2259 · Cited by 320
Metadata
- Authors
- Xiong, H., Zhang, Z.-G., Tian, X.-Q., Sun, D.-F., Liang, Q.-C., Zhang, Y.-J., Lu, R., Chen, Y.-X., & Fang, J.-Y.
- Venue
- Neoplasia
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 10
- Issue
- 3
- Pages
- 287-297
- ISSN
- 1476-5586 (ISSN-L)
- OpenAlex
- W89255747
- Cited by
- 426
- References
- 43
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.